Literature DB >> 19817715

Recent advances in biological strategies for targeted drug delivery.

Xin Ye1, Decheng Yang.   

Abstract

Targeted drug delivery system, consisting of a guidance component, a transport vehicle and the drug, is aiming at distributing the drugs to a specific organ or cell type in a sufficient concentration to achieve the high efficiency and alleviate the side-effects of the drugs. During the past decade, besides physical and chemical methods, biological strategies have been developing at an amazing speed improving the drug targeting system. These include: i) searching for guidance components, which include integrin ligands, extracellular matrix proteins, carbohydrates, vitamins, antibodies, nucleic acid aptamers and peptides, leading the whole system to the targeting sites; ii) development of the transport vehicles, such as polymers and plasmid/virus vectors that play the role in carrying drugs and protecting them on their way to the destination; and iii) the design or selection of an effective drug, the "final bullet" that functions on the targeting site, to test the efficiency of the system. Here, we briefly review the recent advances on the development of the most essential targeted drug delivery systems and strategies, and particularly focusing on the progress in discovery of the ligand components and construction of carrying vehicles for drug targeted delivery systems. In addition, we briefly discuss the prospect of this field.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19817715     DOI: 10.2174/187152909789007025

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  11 in total

1.  Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs.

Authors:  Hui-Ping Lin; Bhupesh Singla; Pushpankur Ghoshal; Jessica L Faulkner; Mary Cherian-Shaw; Paul M O'Connor; Jin-Xiong She; Eric J Belin de Chantemele; Gábor Csányi
Journal:  Br J Pharmacol       Date:  2018-08-01       Impact factor: 8.739

2.  Single intra-articular injection of adeno-associated virus results in stable and controllable in vivo transgene expression in normal rat knees.

Authors:  K A Payne; H H Lee; A M Haleem; C Martins; Z Yuan; C Qiao; X Xiao; C R Chu
Journal:  Osteoarthritis Cartilage       Date:  2011-04-28       Impact factor: 6.576

3.  ABCG2 aptamer selectively delivers doxorubicin to drug-resistant breast cancer cells.

Authors:  Shirin Hashemitabar; Rezvan Yazdian-Robati; Maryam Hashemi; Mohammad Ramezani; Khalil Abnous; Fatemeh Kalalinia
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

4.  Identification of targeting peptides for ischemic myocardium by in vivo phage display.

Authors:  Sachiko Kanki; Diana E Jaalouk; Samuel Lee; Alvin Y C Yu; Joseph Gannon; Richard T Lee
Journal:  J Mol Cell Cardiol       Date:  2011-02-24       Impact factor: 5.000

5.  Localized delivery of antisense oligonucleotides by cationic hydrogel suppresses TNF-α expression and endotoxin-induced osteolysis.

Authors:  Lei Dong; Zhen Huang; Xing Cai; Jiawei Xiang; Yi-An Zhu; Rui Wang; Jiangning Chen; Junfeng Zhang
Journal:  Pharm Res       Date:  2010-12-08       Impact factor: 4.200

6.  Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity.

Authors:  Michael M Galagudza; Dmitry V Korolev; Dmitry L Sonin; Viktor N Postnov; Garry V Papayan; Ivan S Uskov; Anastasia V Belozertseva; Eugene V Shlyakhto
Journal:  Int J Nanomedicine       Date:  2010-04-07

7.  Targeted delivery of mutant tolerant anti-coxsackievirus artificial microRNAs using folate conjugated bacteriophage Phi29 pRNA.

Authors:  Xin Ye; Zhen Liu; Maged Gomaa Hemida; Decheng Yang
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

8.  Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro.

Authors:  Yan Hu; Jinhong Duan; Qimin Zhan; Fengdan Wang; Xin Lu; Xian-Da Yang
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

9.  Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles.

Authors:  Michael Galagudza; Dmitry Korolev; Viktor Postnov; Elena Naumisheva; Yulia Grigorova; Ivan Uskov; Eugene Shlyakhto
Journal:  Int J Nanomedicine       Date:  2012-04-13

10.  Cardioprotection of PLGA/gelatine cardiac patches functionalised with adenosine in a large animal model of ischaemia and reperfusion injury: A feasibility study.

Authors:  Caterina Cristallini; Giuseppe Vaccari; Niccoletta Barbani; Elisa Cibrario Rocchietti; Rossella Barberis; Mimmo Falzone; Karine Cabiale; Giovanni Perona; Elena Bellotti; Raffaella Rastaldo; Silvia Pascale; Pasquale Pagliaro; Claudia Giachino
Journal:  J Tissue Eng Regen Med       Date:  2019-05-31       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.